Common Stock, Shares, Outstanding of Definium Therapeutics, Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Definium Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Definium Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 98,776,265, a 32% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Definium Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 98,776,265 +23,675,502 +32% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 76,774,057 -4,816,434 -5.9% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 75,803,251 +3,728,175 +5.2% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 75,511,375 +4,347,655 +6.1% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 75,100,763 +33,999,460 +83% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 81,590,491 +41,495,783 +103% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 72,075,076 +33,267,917 +86% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 71,163,720 +32,873,609 +86% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 41,101,303 +3,122,167 +8.2% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 40,094,708 +2,553,593 +6.8% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 38,807,159 -387,882,066 -91% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 38,290,111 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 37,979,136 +9,852,722 +35% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 37,541,115 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 426,689,225 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q4 2021 28,126,414 31 Dec 2021 10-K 09 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.